{"brief_title": "Naltrexone in Treatment of Cocaine Dependence - 5", "brief_summary": "The purpose of this study is to determine the efficacy of naltrexone in the treatment of cocaine dependence as measured by: 1) decreased urine benzoylecgonine (BE) levels, 2) decreased cocaine use by self-report, 3) decreased cocaine craving, and 4) retention in treatment.", "detailed_description": "Double-blind, placebo controlled study of the safety and efficacy of naltrexone in treating cocaine dependence in a patient sample that initiated the study while in an inpatient setting and were then followed-up for 3 months as outpatients.", "condition": ["Cocaine-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Naltrexone"], "criteria": "Inclusion Criteria: 1. Meet DSM-III-R criteria for cocaine dependency, 2. 18 to 65 years of age, 3. capable of understanding the study, 4. voluntarily signed consent, 5. male or non-pregnant female using approved form of birth control. Exclusion Criteria: 1. abnormal liver function tests (SGOT, SGPT, or GGT greater than twice the normal values), 2. opioid use within the last 7 days, 3. use of neuroleptics, 4. having a severe acute medical problem, 5. unable to complete psychiatric rating scales, or 6. judged by the investigator to be unlikely to comply with the study protocol", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "keyword": "cocaine dependence", "mesh_term": ["Cocaine-Related Disorders", "Naltrexone", "Cocaine"], "id": "NCT00015080"}